Featuring Co-Author Ray Dorsey, MD, MBA
Join us for a special evening with Dr. Ray Dorsey, renowned neurologist and researcher and co-author of The Parkinson’s Plan, the groundbreaking prescriptive guide to preventing and fighting Parkinson’s disease.
This event will feature a facilitated discussion led by Dr. Dorsey, offering insights from the book and the “Parkinson’s 25” checklist. A reception and book signing will follow, providing guests with the opportunity to meet the author in person.
About The Parkinson’s Plan
The Parkinson’s Plan takes the next step in winning the battle against Parkinson’s, presenting a clear road map with the strategies and tactics necessary to create a world where the disease is increasingly rare and the treatments are more successful. In the book, Dr. Dorsey and Dr. Okun, two doctors on the cutting edge of Parkinson’s research, detail the steps necessary to prevent, slow, and treat this debilitating condition. They show readers how to prevent the disease through the food we eat, the water we drink, the air we breathe, and the lifestyles we live. They introduce the “Parkinson’s 25,” the most detailed checklist ever to prevent and slow the progression of Parkinson’s. They interview the world’s top scientists, clinicians, and thought leaders in the Parkinson’s field to offer a detailed plan for treatment and the latest technological and medical advances. To learn more and order your copy of the book, visit pdplan.org.
About Ray Dorsey, MD, MBA
Dr. Ray Dorsey is the co-author of The Parkinson's Plan, a Professor of Neurology at the University of Rochester, and Director of The Center for Brain & Environment at Atria Health and Research Institute . For the past decade, he has pioneered technology to care for individuals with and measure the features of Parkinson's disease. His research has been published in the leading neurology, medical, and economic journals and been featured on NPR and in The Wall Street Journal, and The New York Times. Previously, Ray directed the Parkinson's disease division at Johns Hopkins Medicine and consulted for McKinsey & Company.
